课题基金 / 基金详情

PATHOGENIC ROLES OF THE ALVEOLAR MACROPHAGE IN ASTHMA

PATHOGENIC ROLES OF THE ALVEOLAR MACROPHAGE IN ASTHMA
肺泡巨噬细胞在哮喘中的致病作用
批准号:
3082203
负责人:
William J Calhoun
金额:
$6.37万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-01 至 1992-08-31

项目摘要

项目成果

William J Calhoun的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Asthma is a disease of great clinical and economic importance, afflicting some nine million young, otherwise healthy individuals. Inflammation is an important aspect of asthma, but many potential determinants of inflammation have not been studied. Roles of the alveolar macrophage (AM) will be determined by these proposed studies. It is likely that these cells contribute to airway inflammation and hyperreactivity by generation of high energy oxygen species (HEOS), release of chemotactins for inflammatory cells such as eosinophils and neutrophils, and elaboration of factors promoting histamine release. Allergic asthmatic subjects will be studied before and after bronchoprovaction (BP) with antigen to which they are sensitive, and AM recovered by bronchoalveolar lavage. HEOS metabolism will be established by biochemical determinations of superoxide and hydrogen peroxide in addition to luminol-enhanced chemiluminescence response. Release of chemotactins for granulocytes will be determined by standard microchemotaxis assays, and AM-derived histamine releasing activity by fluorimetric analysis of histamine. Results from allergic asthma patients after BP will be compared to those obtained from normal controls and allergic rhinitis patients, and to their own values prior to BP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BEST ADJUSTMENT STRATEGY FOR ASTHMA IN THE LONG TERM (BASALT)
SEVERE ASTHMA RESEARCH PROGRAM (SARP)
Severe Asthma Research Program (SARP)
Asthma Clinical Research Network
海外基金